Showing results (11-20 of 267) with videos related to
Sort By:
Pageof 27
Pharmacological Research|May 25, 2005
Clinical perspectives of PARP inhibitorsGrazia Graziani, Csaba SzabóNature Reviews. Drug Discovery|May 3, 2005
Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitorsPrakash Jagtap, Csaba SzabóCurrent Opinion in Anaesthesiology|April 30, 2008
Poly(ADP-ribose) polymerase: a new therapeutic target?Domokos Gerö, Csaba SzabóCurrent Opinion in Pharmacology|February 18, 2006
Role of peroxynitrite in the pathogenesis of cardiovascular complications of diabetesPál Pacher, Csaba SzabóBritish Journal of Pharmacology|January 5, 2011
Hydrogen sulphide and angiogenesis: mechanisms and applicationsCsaba Szabó, Andreas PapapetropoulosShock (Augusta, Ga.)|June 5, 2010
Pathophysiological roles of peroxynitrite in circulatory shockCsaba Szabó, Katalin MódisCurrent Pharmaceutical Design|August 22, 2006
Role of the peroxynitrite-poly (ADP-ribose) polymerase pathway in the pathogenesis of liver injuryDomokos Gero, Csaba SzabóCardiovascular Drug Reviews|October 9, 2007
Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitorsPál Pacher, Csaba SzabóAntioxidants & Redox Signaling|December 17, 2005
Role of poly(ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications: endothelial dysfunction, as a common underlying themePál Pacher, Csaba SzabóCurrent Medicinal Chemistry|February 7, 2003
Poly(ADP-ribose) polymerase inhibitorsGarry J Southan, Csaba SzabóPageof 27